Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Takeda nets first-in-class advantage on narcolepsy drugâs FDA go-ahead
GlobalData previously flagged Orzeyfulâs approval in narcolepsy as a key Q3 catalyst for pharma due to the drugâs âtransformativeâ potential.
Read Full Article
Pharma Tech
Rethinking sterile product development for manufacturing success
How evolving development priorities are helping organisations build manufacturing knowledge from the earliest stages of development.
Read Full Article
Pharma Tech
Eli Lilly raises 2026 outlook again as Q2 soars past estimates
Reporting 91% growth for Mounjaro, Lilly widened the gap to cardiometabolic rival Novo Nordisk.
Read Full Article
Pharma Tech
Alteogen signs $365m Hybrozyme licensing deal with pharma company
Alteogen has signed an exclusive licensing deal worth up to $365m with a global pharmaceutical company, granting worldwide rights to develop and commercialise a subcutaneous biologic product using its Hybrozyme technology.
Read Full Article
Pharma Tech
China-ready by design: Leveraging NMPAâs new 30âworking day IND pathway
China is becoming a global hub for oncology trials, with the NMPA now offering expedited review pathways for INDs.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Aug 6, 2026, 4:48 PM
After Recall, Sun Pharma Lists its Safe-to-Use Eye-care Drugs
Among the products listed by Sun in the "not affected list" are Cequa, Careprost LS, Gatilox DM, Timolet OD, Eyemist Gel, OCeva injection, Synca and Cafta.
ET Pharma
Aug 6, 2026, 3:18 PM
Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case
"The âCourt found that âCeban infringed Novo Nordisk's supplementary protection certificate (SPC) covering semaglutide," the Danish drugmaker said in âa statement.
Pharma Tech
Aug 6, 2026, 1:11 PM
Takeda nets first-in-class advantage on narcolepsy drugâs FDA go-ahead
GlobalData previously flagged Orzeyfulâs approval in narcolepsy as a key Q3 catalyst for pharma due to the drugâs âtransformativeâ potential.
PharmaShots
Aug 6, 2026, 12:30 PM
Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for ~$800M
Shots: Ref: Globenewswire |  Image: Alkeus |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals for ~$800M appeared first on PharmaShots.
PharmaShots
Aug 6, 2026, 11:30 AM
The US FDA Approves Modernaâs mFLUSIVA Against Seasonal Influenza for Adults Aged 50 or More
Shots: Ref: Moderna |  Image: Moderna |  Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post The US FDA Approves Modernaâs mFLUSIVA Against Seasonal Influenza for Adults Aged 50 or More appeared first on PharmaShots.
PharmaShots
Aug 6, 2026, 11:20 AM
Global Clinical Trials Connect 2027 | May 11-12 | London, UK
As clinical trials become increasingly complex and technology-driven, the need for smarter strategies, stronger collaborations, and patient-centric innovation has never been greater. From decentralized clinical trials and artificial intelligence to advanced data management and evolving regulatory frameworks, the clinical research landscape is undergoing a significant transformation. Global Clinical Trials Connect 2027 aims to bring together⊠The post Global Clinical Trials Connect 2027 | May 11-12 | London, UK appeared first on PharmaShots.
News
Latest industry coverage
Google News
Aug 6, 2026, 7:30 PM
Safely Scaling High Potency API Manufacturing - contractpharma.com
Safely Scaling High Potency API Manufacturing  contractpharma.com
Google News
Aug 6, 2026, 7:29 PM
Copeland to Acquire Dickson, Advance Cold Chain Solutions for Healthcare Industry - Supply & Demand Chain Executive
Copeland to Acquire Dickson, Advance Cold Chain Solutions for Healthcare Industry  Supply & Demand Chain Executive
Google News
Aug 6, 2026, 7:16 PM
Evotec, Odyssey Launch R&D Partnership in Autoimmune, Inflammatory Diseases - contractpharma.com
Evotec, Odyssey Launch R&D Partnership in Autoimmune, Inflammatory Diseases  contractpharma.com
Google News
Aug 6, 2026, 7:14 PM
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800M - BioPharma Dive
Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800MÂ Â BioPharma Dive
Google News
Aug 6, 2026, 7:04 PM
Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts - STAT
Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group asserts  STAT
Google News
Aug 6, 2026, 6:59 PM
Battelle Highlights National Security-Focused Biotechnology Capabilities During NSCEB Ohio Visit - Business Wire
Battelle Highlights National Security-Focused Biotechnology Capabilities During NSCEB Ohio Visit  Business Wire
Google News
Aug 6, 2026, 6:18 PM
Big Pharma Can't Merge Its Way Out Of An Innovation Problem - Life Science Leader
Big Pharma Can't Merge Its Way Out Of An Innovation Problem  Life Science Leader
Google News
Aug 6, 2026, 5:47 PM
Most of essential drug pricing off to pvt hands - New Age BD
Most of essential drug pricing off to pvt hands  New Age BD
Google News
Aug 6, 2026, 5:38 PM
AstraZeneca, BMS not pursuing merger talks: Reuters - NJBIZ
AstraZeneca, BMS not pursuing merger talks: Reuters  NJBIZ
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer